Recipharm AB (STO:RECIB), a Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry, announced on Wednesday that it has appointed Tobias Hägglöv as new CFO of the company, effective later in the year. Hägglöv will also be a member of Recipharm's group management team.
Most recently, Hägglöv was CFO at LEAX. Prior to that, Hägglöv has comprehensive experience from finance positions at Electrolux, SAS and Accenture.
Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, as well as pharmaceutical product development.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer